Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy



Status:Recruiting
Conditions:Blood Cancer, Blood Cancer, Hematology
Therapuetic Areas:Hematology, Oncology
Healthy:No
Age Range:18 - 99
Updated:1/6/2019
Start Date:January 2, 2018
End Date:February 2025
Contact:Timothy Krepski, RN
Email:tkrepsk1@fairview.org
Phone:612-273-2800

Use our guide to learn which trials are right for you!

This is a prospective, observational study to collect stool and blood from acute myeloid
leukemia patients undergoing intensive chemotherapy.


Inclusion Criteria:

- Adults (ages 18 - 99 years) undergoing inpatient intensive chemotherapy for newly
diagnosed, refractory, or relapsed AML. Patients may or may not have been exposed to
any type of therapy before.

- Any intensive chemotherapy regimen defined as a planned ~4 week inpatient stay.
Chemotherapy may be delivered for any number of days and on any schedule. Patients may
be discharged from the hospital sooner than 4 weeks if the treating physician choose
so, but the expectation at the initiation of chemotherapy must be ~4 weeks of
inpatient stay, as is typical.

- Able to provide written voluntary consent before performance of any study related
procedure.
We found this trial at
1
site
425 E River Pkwy # 754
Minneapolis, Minnesota 55455
612-624-2620
Phone: 612-963-0539
Masonic Cancer Center at University of Minnesota The Masonic Cancer Center was founded in 1991....
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials